Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B

The negative rate of serum HBV DNA, HBeAg, and ALT in the tenofovir group was significantly higher than that in the entecavir group (86.67%, 3.33%, and 80.00%) (all P < 0.05). In the tenofovir group, 2cases were considered. Objective. The aim of this study is to analyze the clinical effect and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Feng, Xia, Zhongjiang, Wang, Hui, Zhu, Jinjun, Hu, Laiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239785/
https://www.ncbi.nlm.nih.gov/pubmed/35774746
http://dx.doi.org/10.1155/2022/1673453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239785/
https://www.ncbi.nlm.nih.gov/pubmed/35774746
http://dx.doi.org/10.1155/2022/1673453

Ejemplares similares